Alpine Immune Sciences ALPN reported its Q4 earnings results on Monday, March 18, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Alpine Immune Sciences beat estimated earnings by 144.0%, reporting an EPS of $0.15 versus an estimate of $-0.34.
Revenue was up $28.08 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.09 which was followed by a 6.0% increase in the share price the next day.
Here's a look at Alpine Immune Sciences's past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.33 | -0.37 | -0.37 | -0.27 |
| EPS Actual | -0.24 | -0.27 | -0.28 | -0.41 |
| Revenue Estimate | 7.25M | 8.85M | 8.60M | 10.96M |
| Revenue Actual | 10.04M | 8.59M | 9.39M | 2.78M |
To track all earnings releases for Alpine Immune Sciences visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
